Berkshire Hathaway doubles Teva bet, confirms Apple purchases

Berkshire Hathaway doubles Teva bet, confirms Apple purchases

(Reuters) - Warren Buffett's Berkshire Hathaway Inc on Tuesday said it has more than doubled its investment in generic drugmaker Teva Pharmaceutical Industries Ltd , and confirmed it has become Apple Inc's second-largest shareholder.

Berkshire said it owned about 40.5 million Teva American depositary receipts (ADRs) worth about $693 million as of March 31, up from 18.9 million ADRs three months earlier.

The disclosure was made in a filing with the U.S. Securities and Exchange Commission detailing Berkshire's U.S.-listed stock holdings as of March 31.

Berkshire also said it boosted its Apple stake to about 239.6 million shares worth more than $40 billion as of March 31, up from 165.3 million shares three months earlier.

(Reporting by Jonathan Stempel in New York, editing by G Crosse)

This story has not been edited by Firstpost staff and is generated by auto-feed.


Updated Date: May 16, 2018 03:05 AM

Also Watch

IPL 2018: Royal Challengers Bangalore eye revival against Chennai Super Kings as 'Cauvery Derby' comes back to life
  • Thursday, April 26, 2018 In the Kanjarbhat community, a campaign against 'virginity tests' is slowly gaining ground
  • Tuesday, April 24, 2018 It's A Wrap: Beyond the Clouds stars Ishaan Khatter, Malavika Mohanan in conversation with Parul Sharma
  • Monday, April 9, 2018 48 hours with Huawei P20 Pro: Triple camera offering is set to redefine smartphone imaging
  • Monday, April 16, 2018 Rajyavardhan Singh Rathore interview: Sports can't be anyone's fiefdom, we need an ecosystem to nurture raw talent

Also See